Global Natural Killer Cells Therapeutics Market Research Report 2024, Forecast to 2032
Report Overview
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The global Natural Killer Cells Therapeutics market size was estimated at USD 350 million in 2023 and is projected to reach USD 1372.92 million by 2032, exhibiting a CAGR of 16.40% during the forecast period.
North America Natural Killer Cells Therapeutics market size was estimated at USD 118.64 million in 2023, at a CAGR of 14.06% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Natural Killer Cells Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Natural Killer Cells Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Natural Killer Cells Therapeutics market in any manner.
Global Natural Killer Cells Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Affimed
Celgene
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology
Market Segmentation (by Type)
NK Cell Therapies
NK Cell Directed Antibodies
Market Segmentation (by Application)
Cancer
Gastrointestinal Diseases
Immunoproliferative Disorders
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Natural Killer Cells Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Natural Killer Cells Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The global Natural Killer Cells Therapeutics market size was estimated at USD 350 million in 2023 and is projected to reach USD 1372.92 million by 2032, exhibiting a CAGR of 16.40% during the forecast period.
North America Natural Killer Cells Therapeutics market size was estimated at USD 118.64 million in 2023, at a CAGR of 14.06% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Natural Killer Cells Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Natural Killer Cells Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Natural Killer Cells Therapeutics market in any manner.
Global Natural Killer Cells Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Affimed
Celgene
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology
Market Segmentation (by Type)
NK Cell Therapies
NK Cell Directed Antibodies
Market Segmentation (by Application)
Cancer
Gastrointestinal Diseases
Immunoproliferative Disorders
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Natural Killer Cells Therapeutics Market
- Overview of the regional outlook of the Natural Killer Cells Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Natural Killer Cells Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Natural Killer Cells Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Natural Killer Cells Therapeutics
1.2 Key Market Segments
1.2.1 Natural Killer Cells Therapeutics Segment by Type
1.2.2 Natural Killer Cells Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NATURAL KILLER CELLS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Natural Killer Cells Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Natural Killer Cells Therapeutics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NATURAL KILLER CELLS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Natural Killer Cells Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Natural Killer Cells Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Natural Killer Cells Therapeutics Sales Sites, Area Served, Product Type
3.6 Natural Killer Cells Therapeutics Market Competitive Situation and Trends
3.6.1 Natural Killer Cells Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Natural Killer Cells Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NATURAL KILLER CELLS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Natural Killer Cells Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NATURAL KILLER CELLS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NATURAL KILLER CELLS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Natural Killer Cells Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Natural Killer Cells Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Natural Killer Cells Therapeutics Price by Type (2019-2024)
7 NATURAL KILLER CELLS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Natural Killer Cells Therapeutics Market Sales by Application (2019-2024)
7.3 Global Natural Killer Cells Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2019-2024)
8 NATURAL KILLER CELLS THERAPEUTICS MARKET CONSUMPTION BY REGION
8.1 Global Natural Killer Cells Therapeutics Sales by Region
8.1.1 Global Natural Killer Cells Therapeutics Sales by Region
8.1.2 Global Natural Killer Cells Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Natural Killer Cells Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Natural Killer Cells Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Natural Killer Cells Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Natural Killer Cells Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Natural Killer Cells Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 NATURAL KILLER CELLS THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Natural Killer Cells Therapeutics by Region (2019-2024)
9.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Region (2019-2024)
9.3 Global Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Natural Killer Cells Therapeutics Production
9.4.1 North America Natural Killer Cells Therapeutics Production Growth Rate (2019-2024)
9.4.2 North America Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Natural Killer Cells Therapeutics Production
9.5.1 Europe Natural Killer Cells Therapeutics Production Growth Rate (2019-2024)
9.5.2 Europe Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Natural Killer Cells Therapeutics Production (2019-2024)
9.6.1 Japan Natural Killer Cells Therapeutics Production Growth Rate (2019-2024)
9.6.2 Japan Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Natural Killer Cells Therapeutics Production (2019-2024)
9.7.1 China Natural Killer Cells Therapeutics Production Growth Rate (2019-2024)
9.7.2 China Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Affimed
10.1.1 Affimed Natural Killer Cells Therapeutics Basic Information
10.1.2 Affimed Natural Killer Cells Therapeutics Product Overview
10.1.3 Affimed Natural Killer Cells Therapeutics Product Market Performance
10.1.4 Affimed Business Overview
10.1.5 Affimed Natural Killer Cells Therapeutics SWOT Analysis
10.1.6 Affimed Recent Developments
10.2 Celgene
10.2.1 Celgene Natural Killer Cells Therapeutics Basic Information
10.2.2 Celgene Natural Killer Cells Therapeutics Product Overview
10.2.3 Celgene Natural Killer Cells Therapeutics Product Market Performance
10.2.4 Celgene Business Overview
10.2.5 Celgene Natural Killer Cells Therapeutics SWOT Analysis
10.2.6 Celgene Recent Developments
10.3 Fate Therapeutics
10.3.1 Fate Therapeutics Natural Killer Cells Therapeutics Basic Information
10.3.2 Fate Therapeutics Natural Killer Cells Therapeutics Product Overview
10.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.3.4 Fate Therapeutics Natural Killer Cells Therapeutics SWOT Analysis
10.3.5 Fate Therapeutics Business Overview
10.3.6 Fate Therapeutics Recent Developments
10.4 Fortress Biotech
10.4.1 Fortress Biotech Natural Killer Cells Therapeutics Basic Information
10.4.2 Fortress Biotech Natural Killer Cells Therapeutics Product Overview
10.4.3 Fortress Biotech Natural Killer Cells Therapeutics Product Market Performance
10.4.4 Fortress Biotech Business Overview
10.4.5 Fortress Biotech Recent Developments
10.5 Glycostem Therapeutics
10.5.1 Glycostem Therapeutics Natural Killer Cells Therapeutics Basic Information
10.5.2 Glycostem Therapeutics Natural Killer Cells Therapeutics Product Overview
10.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.5.4 Glycostem Therapeutics Business Overview
10.5.5 Glycostem Therapeutics Recent Developments
10.6 Innate Pharma
10.6.1 Innate Pharma Natural Killer Cells Therapeutics Basic Information
10.6.2 Innate Pharma Natural Killer Cells Therapeutics Product Overview
10.6.3 Innate Pharma Natural Killer Cells Therapeutics Product Market Performance
10.6.4 Innate Pharma Business Overview
10.6.5 Innate Pharma Recent Developments
10.7 Nantkwest
10.7.1 Nantkwest Natural Killer Cells Therapeutics Basic Information
10.7.2 Nantkwest Natural Killer Cells Therapeutics Product Overview
10.7.3 Nantkwest Natural Killer Cells Therapeutics Product Market Performance
10.7.4 Nantkwest Business Overview
10.7.5 Nantkwest Recent Developments
10.8 Nkarta Therapeutics
10.8.1 Nkarta Therapeutics Natural Killer Cells Therapeutics Basic Information
10.8.2 Nkarta Therapeutics Natural Killer Cells Therapeutics Product Overview
10.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.8.4 Nkarta Therapeutics Business Overview
10.8.5 Nkarta Therapeutics Recent Developments
10.9 NKT Therapeutics
10.9.1 NKT Therapeutics Natural Killer Cells Therapeutics Basic Information
10.9.2 NKT Therapeutics Natural Killer Cells Therapeutics Product Overview
10.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.9.4 NKT Therapeutics Business Overview
10.9.5 NKT Therapeutics Recent Developments
10.10 Ziopharm Oncology
10.10.1 Ziopharm Oncology Natural Killer Cells Therapeutics Basic Information
10.10.2 Ziopharm Oncology Natural Killer Cells Therapeutics Product Overview
10.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Product Market Performance
10.10.4 Ziopharm Oncology Business Overview
10.10.5 Ziopharm Oncology Recent Developments
11 NATURAL KILLER CELLS THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Natural Killer Cells Therapeutics Market Size Forecast
11.2 Global Natural Killer Cells Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Natural Killer Cells Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Natural Killer Cells Therapeutics Market Size Forecast by Region
11.2.4 South America Natural Killer Cells Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Natural Killer Cells Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Natural Killer Cells Therapeutics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Natural Killer Cells Therapeutics by Type (2025-2032)
12.1.2 Global Natural Killer Cells Therapeutics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Natural Killer Cells Therapeutics by Type (2025-2032)
12.2 Global Natural Killer Cells Therapeutics Market Forecast by Application (2025-2032)
12.2.1 Global Natural Killer Cells Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Natural Killer Cells Therapeutics Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Natural Killer Cells Therapeutics
1.2 Key Market Segments
1.2.1 Natural Killer Cells Therapeutics Segment by Type
1.2.2 Natural Killer Cells Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NATURAL KILLER CELLS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Natural Killer Cells Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Natural Killer Cells Therapeutics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NATURAL KILLER CELLS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Natural Killer Cells Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Natural Killer Cells Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Natural Killer Cells Therapeutics Sales Sites, Area Served, Product Type
3.6 Natural Killer Cells Therapeutics Market Competitive Situation and Trends
3.6.1 Natural Killer Cells Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Natural Killer Cells Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NATURAL KILLER CELLS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Natural Killer Cells Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NATURAL KILLER CELLS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NATURAL KILLER CELLS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Natural Killer Cells Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Natural Killer Cells Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Natural Killer Cells Therapeutics Price by Type (2019-2024)
7 NATURAL KILLER CELLS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Natural Killer Cells Therapeutics Market Sales by Application (2019-2024)
7.3 Global Natural Killer Cells Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2019-2024)
8 NATURAL KILLER CELLS THERAPEUTICS MARKET CONSUMPTION BY REGION
8.1 Global Natural Killer Cells Therapeutics Sales by Region
8.1.1 Global Natural Killer Cells Therapeutics Sales by Region
8.1.2 Global Natural Killer Cells Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Natural Killer Cells Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Natural Killer Cells Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Natural Killer Cells Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Natural Killer Cells Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Natural Killer Cells Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 NATURAL KILLER CELLS THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Natural Killer Cells Therapeutics by Region (2019-2024)
9.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Region (2019-2024)
9.3 Global Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Natural Killer Cells Therapeutics Production
9.4.1 North America Natural Killer Cells Therapeutics Production Growth Rate (2019-2024)
9.4.2 North America Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Natural Killer Cells Therapeutics Production
9.5.1 Europe Natural Killer Cells Therapeutics Production Growth Rate (2019-2024)
9.5.2 Europe Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Natural Killer Cells Therapeutics Production (2019-2024)
9.6.1 Japan Natural Killer Cells Therapeutics Production Growth Rate (2019-2024)
9.6.2 Japan Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Natural Killer Cells Therapeutics Production (2019-2024)
9.7.1 China Natural Killer Cells Therapeutics Production Growth Rate (2019-2024)
9.7.2 China Natural Killer Cells Therapeutics Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Affimed
10.1.1 Affimed Natural Killer Cells Therapeutics Basic Information
10.1.2 Affimed Natural Killer Cells Therapeutics Product Overview
10.1.3 Affimed Natural Killer Cells Therapeutics Product Market Performance
10.1.4 Affimed Business Overview
10.1.5 Affimed Natural Killer Cells Therapeutics SWOT Analysis
10.1.6 Affimed Recent Developments
10.2 Celgene
10.2.1 Celgene Natural Killer Cells Therapeutics Basic Information
10.2.2 Celgene Natural Killer Cells Therapeutics Product Overview
10.2.3 Celgene Natural Killer Cells Therapeutics Product Market Performance
10.2.4 Celgene Business Overview
10.2.5 Celgene Natural Killer Cells Therapeutics SWOT Analysis
10.2.6 Celgene Recent Developments
10.3 Fate Therapeutics
10.3.1 Fate Therapeutics Natural Killer Cells Therapeutics Basic Information
10.3.2 Fate Therapeutics Natural Killer Cells Therapeutics Product Overview
10.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.3.4 Fate Therapeutics Natural Killer Cells Therapeutics SWOT Analysis
10.3.5 Fate Therapeutics Business Overview
10.3.6 Fate Therapeutics Recent Developments
10.4 Fortress Biotech
10.4.1 Fortress Biotech Natural Killer Cells Therapeutics Basic Information
10.4.2 Fortress Biotech Natural Killer Cells Therapeutics Product Overview
10.4.3 Fortress Biotech Natural Killer Cells Therapeutics Product Market Performance
10.4.4 Fortress Biotech Business Overview
10.4.5 Fortress Biotech Recent Developments
10.5 Glycostem Therapeutics
10.5.1 Glycostem Therapeutics Natural Killer Cells Therapeutics Basic Information
10.5.2 Glycostem Therapeutics Natural Killer Cells Therapeutics Product Overview
10.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.5.4 Glycostem Therapeutics Business Overview
10.5.5 Glycostem Therapeutics Recent Developments
10.6 Innate Pharma
10.6.1 Innate Pharma Natural Killer Cells Therapeutics Basic Information
10.6.2 Innate Pharma Natural Killer Cells Therapeutics Product Overview
10.6.3 Innate Pharma Natural Killer Cells Therapeutics Product Market Performance
10.6.4 Innate Pharma Business Overview
10.6.5 Innate Pharma Recent Developments
10.7 Nantkwest
10.7.1 Nantkwest Natural Killer Cells Therapeutics Basic Information
10.7.2 Nantkwest Natural Killer Cells Therapeutics Product Overview
10.7.3 Nantkwest Natural Killer Cells Therapeutics Product Market Performance
10.7.4 Nantkwest Business Overview
10.7.5 Nantkwest Recent Developments
10.8 Nkarta Therapeutics
10.8.1 Nkarta Therapeutics Natural Killer Cells Therapeutics Basic Information
10.8.2 Nkarta Therapeutics Natural Killer Cells Therapeutics Product Overview
10.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.8.4 Nkarta Therapeutics Business Overview
10.8.5 Nkarta Therapeutics Recent Developments
10.9 NKT Therapeutics
10.9.1 NKT Therapeutics Natural Killer Cells Therapeutics Basic Information
10.9.2 NKT Therapeutics Natural Killer Cells Therapeutics Product Overview
10.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Product Market Performance
10.9.4 NKT Therapeutics Business Overview
10.9.5 NKT Therapeutics Recent Developments
10.10 Ziopharm Oncology
10.10.1 Ziopharm Oncology Natural Killer Cells Therapeutics Basic Information
10.10.2 Ziopharm Oncology Natural Killer Cells Therapeutics Product Overview
10.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Product Market Performance
10.10.4 Ziopharm Oncology Business Overview
10.10.5 Ziopharm Oncology Recent Developments
11 NATURAL KILLER CELLS THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Natural Killer Cells Therapeutics Market Size Forecast
11.2 Global Natural Killer Cells Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Natural Killer Cells Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Natural Killer Cells Therapeutics Market Size Forecast by Region
11.2.4 South America Natural Killer Cells Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Natural Killer Cells Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Natural Killer Cells Therapeutics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Natural Killer Cells Therapeutics by Type (2025-2032)
12.1.2 Global Natural Killer Cells Therapeutics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Natural Killer Cells Therapeutics by Type (2025-2032)
12.2 Global Natural Killer Cells Therapeutics Market Forecast by Application (2025-2032)
12.2.1 Global Natural Killer Cells Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Natural Killer Cells Therapeutics Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Natural Killer Cells Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Natural Killer Cells Therapeutics Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Natural Killer Cells Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Natural Killer Cells Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Natural Killer Cells Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2022)
Table 10. Global Market Natural Killer Cells Therapeutics Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Natural Killer Cells Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Natural Killer Cells Therapeutics Product Type
Table 13. Global Natural Killer Cells Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Natural Killer Cells Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Natural Killer Cells Therapeutics Market Challenges
Table 22. Global Natural Killer Cells Therapeutics Sales by Type (K MT)
Table 23. Global Natural Killer Cells Therapeutics Market Size by Type (M USD)
Table 24. Global Natural Killer Cells Therapeutics Sales (K MT) by Type (2019-2024)
Table 25. Global Natural Killer Cells Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Natural Killer Cells Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Natural Killer Cells Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Natural Killer Cells Therapeutics Price (USD/MT) by Type (2019-2024)
Table 29. Global Natural Killer Cells Therapeutics Sales (K MT) by Application
Table 30. Global Natural Killer Cells Therapeutics Market Size by Application
Table 31. Global Natural Killer Cells Therapeutics Sales by Application (2019-2024) & (K MT)
Table 32. Global Natural Killer Cells Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Natural Killer Cells Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Natural Killer Cells Therapeutics Market Share by Application (2019-2024)
Table 35. Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Natural Killer Cells Therapeutics Sales by Region (2019-2024) & (K MT)
Table 37. Global Natural Killer Cells Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Natural Killer Cells Therapeutics Sales by Country (2019-2024) & (K MT)
Table 39. Europe Natural Killer Cells Therapeutics Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Natural Killer Cells Therapeutics Sales by Region (2019-2024) & (K MT)
Table 41. South America Natural Killer Cells Therapeutics Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Natural Killer Cells Therapeutics Sales by Region (2019-2024) & (K MT)
Table 43. Global Natural Killer Cells Therapeutics Production (K MT) by Region (2019-2024)
Table 44. Global Natural Killer Cells Therapeutics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Natural Killer Cells Therapeutics Revenue Market Share by Region (2019-2024)
Table 46. Global Natural Killer Cells Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Natural Killer Cells Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Natural Killer Cells Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Natural Killer Cells Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Natural Killer Cells Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Affimed Natural Killer Cells Therapeutics Basic Information
Table 52. Affimed Natural Killer Cells Therapeutics Product Overview
Table 53. Affimed Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Affimed Business Overview
Table 55. Affimed Natural Killer Cells Therapeutics SWOT Analysis
Table 56. Affimed Recent Developments
Table 57. Celgene Natural Killer Cells Therapeutics Basic Information
Table 58. Celgene Natural Killer Cells Therapeutics Product Overview
Table 59. Celgene Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Celgene Business Overview
Table 61. Celgene Natural Killer Cells Therapeutics SWOT Analysis
Table 62. Celgene Recent Developments
Table 63. Fate Therapeutics Natural Killer Cells Therapeutics Basic Information
Table 64. Fate Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 65. Fate Therapeutics Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Fate Therapeutics Natural Killer Cells Therapeutics SWOT Analysis
Table 67. Fate Therapeutics Business Overview
Table 68. Fate Therapeutics Recent Developments
Table 69. Fortress Biotech Natural Killer Cells Therapeutics Basic Information
Table 70. Fortress Biotech Natural Killer Cells Therapeutics Product Overview
Table 71. Fortress Biotech Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Fortress Biotech Business Overview
Table 73. Fortress Biotech Recent Developments
Table 74. Glycostem Therapeutics Natural Killer Cells Therapeutics Basic Information
Table 75. Glycostem Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 76. Glycostem Therapeutics Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Glycostem Therapeutics Business Overview
Table 78. Glycostem Therapeutics Recent Developments
Table 79. Innate Pharma Natural Killer Cells Therapeutics Basic Information
Table 80. Innate Pharma Natural Killer Cells Therapeutics Product Overview
Table 81. Innate Pharma Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Innate Pharma Business Overview
Table 83. Innate Pharma Recent Developments
Table 84. Nantkwest Natural Killer Cells Therapeutics Basic Information
Table 85. Nantkwest Natural Killer Cells Therapeutics Product Overview
Table 86. Nantkwest Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Nantkwest Business Overview
Table 88. Nantkwest Recent Developments
Table 89. Nkarta Therapeutics Natural Killer Cells Therapeutics Basic Information
Table 90. Nkarta Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 91. Nkarta Therapeutics Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Nkarta Therapeutics Business Overview
Table 93. Nkarta Therapeutics Recent Developments
Table 94. NKT Therapeutics Natural Killer Cells Therapeutics Basic Information
Table 95. NKT Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 96. NKT Therapeutics Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. NKT Therapeutics Business Overview
Table 98. NKT Therapeutics Recent Developments
Table 99. Ziopharm Oncology Natural Killer Cells Therapeutics Basic Information
Table 100. Ziopharm Oncology Natural Killer Cells Therapeutics Product Overview
Table 101. Ziopharm Oncology Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Ziopharm Oncology Business Overview
Table 103. Ziopharm Oncology Recent Developments
Table 104. Global Natural Killer Cells Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 105. Global Natural Killer Cells Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Natural Killer Cells Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 107. North America Natural Killer Cells Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Natural Killer Cells Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 109. Europe Natural Killer Cells Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Natural Killer Cells Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 111. Asia Pacific Natural Killer Cells Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Natural Killer Cells Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 113. South America Natural Killer Cells Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Natural Killer Cells Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Natural Killer Cells Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Natural Killer Cells Therapeutics Sales Forecast by Type (2025-2032) & (K MT)
Table 117. Global Natural Killer Cells Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Natural Killer Cells Therapeutics Price Forecast by Type (2025-2032) & (USD/MT)
Table 119. Global Natural Killer Cells Therapeutics Sales (K MT) Forecast by Application (2025-2032)
Table 120. Global Natural Killer Cells Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Natural Killer Cells Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Natural Killer Cells Therapeutics Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Natural Killer Cells Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Natural Killer Cells Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Natural Killer Cells Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2022)
Table 10. Global Market Natural Killer Cells Therapeutics Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Natural Killer Cells Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Natural Killer Cells Therapeutics Product Type
Table 13. Global Natural Killer Cells Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Natural Killer Cells Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Natural Killer Cells Therapeutics Market Challenges
Table 22. Global Natural Killer Cells Therapeutics Sales by Type (K MT)
Table 23. Global Natural Killer Cells Therapeutics Market Size by Type (M USD)
Table 24. Global Natural Killer Cells Therapeutics Sales (K MT) by Type (2019-2024)
Table 25. Global Natural Killer Cells Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Natural Killer Cells Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Natural Killer Cells Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Natural Killer Cells Therapeutics Price (USD/MT) by Type (2019-2024)
Table 29. Global Natural Killer Cells Therapeutics Sales (K MT) by Application
Table 30. Global Natural Killer Cells Therapeutics Market Size by Application
Table 31. Global Natural Killer Cells Therapeutics Sales by Application (2019-2024) & (K MT)
Table 32. Global Natural Killer Cells Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Natural Killer Cells Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Natural Killer Cells Therapeutics Market Share by Application (2019-2024)
Table 35. Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Natural Killer Cells Therapeutics Sales by Region (2019-2024) & (K MT)
Table 37. Global Natural Killer Cells Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Natural Killer Cells Therapeutics Sales by Country (2019-2024) & (K MT)
Table 39. Europe Natural Killer Cells Therapeutics Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Natural Killer Cells Therapeutics Sales by Region (2019-2024) & (K MT)
Table 41. South America Natural Killer Cells Therapeutics Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Natural Killer Cells Therapeutics Sales by Region (2019-2024) & (K MT)
Table 43. Global Natural Killer Cells Therapeutics Production (K MT) by Region (2019-2024)
Table 44. Global Natural Killer Cells Therapeutics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Natural Killer Cells Therapeutics Revenue Market Share by Region (2019-2024)
Table 46. Global Natural Killer Cells Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Natural Killer Cells Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Natural Killer Cells Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Natural Killer Cells Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Natural Killer Cells Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Affimed Natural Killer Cells Therapeutics Basic Information
Table 52. Affimed Natural Killer Cells Therapeutics Product Overview
Table 53. Affimed Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Affimed Business Overview
Table 55. Affimed Natural Killer Cells Therapeutics SWOT Analysis
Table 56. Affimed Recent Developments
Table 57. Celgene Natural Killer Cells Therapeutics Basic Information
Table 58. Celgene Natural Killer Cells Therapeutics Product Overview
Table 59. Celgene Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Celgene Business Overview
Table 61. Celgene Natural Killer Cells Therapeutics SWOT Analysis
Table 62. Celgene Recent Developments
Table 63. Fate Therapeutics Natural Killer Cells Therapeutics Basic Information
Table 64. Fate Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 65. Fate Therapeutics Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Fate Therapeutics Natural Killer Cells Therapeutics SWOT Analysis
Table 67. Fate Therapeutics Business Overview
Table 68. Fate Therapeutics Recent Developments
Table 69. Fortress Biotech Natural Killer Cells Therapeutics Basic Information
Table 70. Fortress Biotech Natural Killer Cells Therapeutics Product Overview
Table 71. Fortress Biotech Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Fortress Biotech Business Overview
Table 73. Fortress Biotech Recent Developments
Table 74. Glycostem Therapeutics Natural Killer Cells Therapeutics Basic Information
Table 75. Glycostem Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 76. Glycostem Therapeutics Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Glycostem Therapeutics Business Overview
Table 78. Glycostem Therapeutics Recent Developments
Table 79. Innate Pharma Natural Killer Cells Therapeutics Basic Information
Table 80. Innate Pharma Natural Killer Cells Therapeutics Product Overview
Table 81. Innate Pharma Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Innate Pharma Business Overview
Table 83. Innate Pharma Recent Developments
Table 84. Nantkwest Natural Killer Cells Therapeutics Basic Information
Table 85. Nantkwest Natural Killer Cells Therapeutics Product Overview
Table 86. Nantkwest Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Nantkwest Business Overview
Table 88. Nantkwest Recent Developments
Table 89. Nkarta Therapeutics Natural Killer Cells Therapeutics Basic Information
Table 90. Nkarta Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 91. Nkarta Therapeutics Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Nkarta Therapeutics Business Overview
Table 93. Nkarta Therapeutics Recent Developments
Table 94. NKT Therapeutics Natural Killer Cells Therapeutics Basic Information
Table 95. NKT Therapeutics Natural Killer Cells Therapeutics Product Overview
Table 96. NKT Therapeutics Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. NKT Therapeutics Business Overview
Table 98. NKT Therapeutics Recent Developments
Table 99. Ziopharm Oncology Natural Killer Cells Therapeutics Basic Information
Table 100. Ziopharm Oncology Natural Killer Cells Therapeutics Product Overview
Table 101. Ziopharm Oncology Natural Killer Cells Therapeutics Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Ziopharm Oncology Business Overview
Table 103. Ziopharm Oncology Recent Developments
Table 104. Global Natural Killer Cells Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 105. Global Natural Killer Cells Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Natural Killer Cells Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 107. North America Natural Killer Cells Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Natural Killer Cells Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 109. Europe Natural Killer Cells Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Natural Killer Cells Therapeutics Sales Forecast by Region (2025-2032) & (K MT)
Table 111. Asia Pacific Natural Killer Cells Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Natural Killer Cells Therapeutics Sales Forecast by Country (2025-2032) & (K MT)
Table 113. South America Natural Killer Cells Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Natural Killer Cells Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Natural Killer Cells Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Natural Killer Cells Therapeutics Sales Forecast by Type (2025-2032) & (K MT)
Table 117. Global Natural Killer Cells Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Natural Killer Cells Therapeutics Price Forecast by Type (2025-2032) & (USD/MT)
Table 119. Global Natural Killer Cells Therapeutics Sales (K MT) Forecast by Application (2025-2032)
Table 120. Global Natural Killer Cells Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Natural Killer Cells Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Natural Killer Cells Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Natural Killer Cells Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Natural Killer Cells Therapeutics Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Natural Killer Cells Therapeutics Market Size by Country (M USD)
Figure 11. Natural Killer Cells Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Natural Killer Cells Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Natural Killer Cells Therapeutics Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Natural Killer Cells Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Natural Killer Cells Therapeutics Market Share by Type
Figure 18. Sales Market Share of Natural Killer Cells Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Natural Killer Cells Therapeutics by Type in 2023
Figure 20. Market Size Share of Natural Killer Cells Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Natural Killer Cells Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Natural Killer Cells Therapeutics Market Share by Application
Figure 24. Global Natural Killer Cells Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Natural Killer Cells Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Natural Killer Cells Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Natural Killer Cells Therapeutics Market Share by Application in 2023
Figure 28. Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Natural Killer Cells Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Natural Killer Cells Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Natural Killer Cells Therapeutics Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Natural Killer Cells Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Natural Killer Cells Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Natural Killer Cells Therapeutics Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Natural Killer Cells Therapeutics Sales Market Share by Region in 2023
Figure 44. China Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Natural Killer Cells Therapeutics Sales and Growth Rate (K MT)
Figure 50. South America Natural Killer Cells Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Natural Killer Cells Therapeutics Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Natural Killer Cells Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Natural Killer Cells Therapeutics Production Market Share by Region (2019-2024)
Figure 62. North America Natural Killer Cells Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Natural Killer Cells Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Natural Killer Cells Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 65. China Natural Killer Cells Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Natural Killer Cells Therapeutics Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Natural Killer Cells Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Natural Killer Cells Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Natural Killer Cells Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Natural Killer Cells Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Natural Killer Cells Therapeutics Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Natural Killer Cells Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Natural Killer Cells Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Natural Killer Cells Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Natural Killer Cells Therapeutics Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Natural Killer Cells Therapeutics Market Size by Country (M USD)
Figure 11. Natural Killer Cells Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Natural Killer Cells Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Natural Killer Cells Therapeutics Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Natural Killer Cells Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Natural Killer Cells Therapeutics Market Share by Type
Figure 18. Sales Market Share of Natural Killer Cells Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Natural Killer Cells Therapeutics by Type in 2023
Figure 20. Market Size Share of Natural Killer Cells Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Natural Killer Cells Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Natural Killer Cells Therapeutics Market Share by Application
Figure 24. Global Natural Killer Cells Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Natural Killer Cells Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Natural Killer Cells Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Natural Killer Cells Therapeutics Market Share by Application in 2023
Figure 28. Global Natural Killer Cells Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Natural Killer Cells Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Natural Killer Cells Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Natural Killer Cells Therapeutics Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Natural Killer Cells Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Natural Killer Cells Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Natural Killer Cells Therapeutics Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Natural Killer Cells Therapeutics Sales Market Share by Region in 2023
Figure 44. China Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Natural Killer Cells Therapeutics Sales and Growth Rate (K MT)
Figure 50. South America Natural Killer Cells Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Natural Killer Cells Therapeutics Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Natural Killer Cells Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Natural Killer Cells Therapeutics Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Natural Killer Cells Therapeutics Production Market Share by Region (2019-2024)
Figure 62. North America Natural Killer Cells Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Natural Killer Cells Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Natural Killer Cells Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 65. China Natural Killer Cells Therapeutics Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Natural Killer Cells Therapeutics Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Natural Killer Cells Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Natural Killer Cells Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Natural Killer Cells Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Natural Killer Cells Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Natural Killer Cells Therapeutics Market Share Forecast by Application (2025-2032)
